oxymorphone hydrochloride

Key facts

INN

oxymorphone hydrochloride

Brand

OXYMORPHONE HYDROCHLORIDE

Route

RECTAL

Formulation

TABLET, EXTENDED RELEASE

Originator

TEVA PHARMACEUTICAL INDUSTRIES LTD

Related patents

patent

US 12005054

Piperidinyl-3-(aryloxy)propanamides and propanoates

Expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 11045457

Piperidinyl-3-(aryloxy)propanamides and propanoates

Expires Mon Jun 24 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10968213

Cyclopropanamine compound and use thereof

Expires Mon Apr 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10414761

Cyclopropanamine compound and use thereof

Expires Mon Sep 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10233142

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]p

Expires Mon Mar 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 10053456

Cyclopropanamine compound and use thereof

Expires Mon Aug 16 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9920047

Cyclopropanamine compound and use thereof

Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

patent

US 9850199

Metabolites of (1R-trans)-N-[[2-(2,3-dihydro-4-benzofuranyl)cyclopropyl]methyl]p

Expires Mon Dec 21 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

Frequently asked questions

What is oxymorphone hydrochloride?

oxymorphone hydrochloride (OXYMORPHONE HYDROCHLORIDE), is a pharmaceutical active ingredient, associated with TEVA PHARMACEUTICAL INDUSTRIES LTD, with approved status in the US.

What is the brand name for oxymorphone hydrochloride?

OXYMORPHONE HYDROCHLORIDE is a marketed brand name for oxymorphone hydrochloride. Check FDA Drugs@FDA for the current US label holder.